Table 2 The applicability of exon 51, exon 53, and exon 45 skipping for patients with deletion mutation
From: Comprehensive genetic characteristics of dystrophinopathies in China
Skipped exon | Deleted exon | Number of patients |
|---|---|---|
51 | 50 | 15 |
| Â | 52 | 20 |
|  | 17–50 | 1 |
|  | 3–50 | 1 |
|  | 30–50 | 1 |
|  | 45–50 | 44 |
|  | 47–50 | 2 |
|  | 48–50 | 26 |
|  | 49–50 | 31 |
| Â | Â | total 141 (18.8% of all) |
53 | 52 | 20 |
|  | 43–52 | 1 |
|  | 45–52 | 30 |
|  | 47–52 | 3 |
|  | 48–52 | 30 |
|  | 49–52 | 26 |
|  | 50–52 | 5 |
| Â | Â | total 115 (15.3% of all) |
45 | 44 | 18 |
| Â | 46 | 1 |
|  | 12–44 | 2 |
|  | 18–44 | 2 |
|  | 46–47 | 26 |
|  | 46–48 | 8 |
|  | 46–49 | 8 |
|  | 46–51 | 15 |
|  | 46–55 | 2 |
|  | 46–57 | 2 |
| Â | Â | total 84 (11.2% of all) |